These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25011007)

  • 1. Characterization of a shortened model of diet alternation in female rats: effects of the CB1 receptor antagonist rimonabant on food intake and anxiety-like behavior.
    Blasio A; Rice KC; Sabino V; Cottone P
    Behav Pharmacol; 2014 Oct; 25(7):609-17. PubMed ID: 25011007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food.
    Dore R; Valenza M; Wang X; Rice KC; Sabino V; Cottone P
    Addict Biol; 2014 Sep; 19(5):849-61. PubMed ID: 23587012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.
    Blasio A; Iemolo A; Sabino V; Petrosino S; Steardo L; Rice KC; Orlando P; Iannotti FA; Di Marzo V; Zorrilla EP; Cottone P
    Neuropsychopharmacology; 2013 Nov; 38(12):2498-507. PubMed ID: 23793355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food.
    Iemolo A; Blasio A; St Cyr SA; Jiang F; Rice KC; Sabino V; Cottone P
    Neuropsychopharmacology; 2013 Nov; 38(12):2456-66. PubMed ID: 23748225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.
    Gamble-George JC; Conger JR; Hartley ND; Gupta P; Sumislawski JJ; Patel S
    Psychopharmacology (Berl); 2013 Aug; 228(3):401-9. PubMed ID: 23483200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CB1 and CRF1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: lack of withdrawal-like responses.
    Parylak SL; Cottone P; Sabino V; Rice KC; Zorrilla EP
    Physiol Behav; 2012 Sep; 107(2):231-42. PubMed ID: 22776620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A behavioral and pharmacological characterization of palatable diet alternation in mice.
    Moore CF; Schlain GS; Mancino S; Sabino V; Cottone P
    Pharmacol Biochem Behav; 2017 Dec; 163():1-8. PubMed ID: 29097161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet.
    Wierucka-Rybak M; Wolak M; Bojanowska E
    J Physiol Pharmacol; 2014 Aug; 65(4):487-96. PubMed ID: 25179081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal from chronic, intermittent access to a highly palatable food induces depressive-like behavior in compulsive eating rats.
    Iemolo A; Valenza M; Tozier L; Knapp CM; Kornetsky C; Steardo L; Sabino V; Cottone P
    Behav Pharmacol; 2012 Sep; 23(5-6):593-602. PubMed ID: 22854309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.
    Thornton-Jones ZD; Kennett GA; Benwell KR; Revell DF; Misra A; Sellwood DM; Vickers SP; Clifton PG
    Pharmacol Biochem Behav; 2006 Jun; 84(2):353-9. PubMed ID: 16814374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats.
    Gessa GL; Orrù A; Lai P; Maccioni P; Lecca R; Lobina C; Carai MA; Colombo G
    Psychopharmacology (Berl); 2006 Apr; 185(2):248-54. PubMed ID: 16491428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats.
    Mathes CM; Ferrara M; Rowland NE
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R67-75. PubMed ID: 18448611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of a palatable dietary option is not preferentially reduced by cannabinoid CB1 receptor antagonist AM251 in female C57Bl/6J mice.
    Mathes CM; Ferrara M; Rowland NE
    Pharmacol Biochem Behav; 2009 Nov; 94(1):119-23. PubMed ID: 19660493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.
    Scherma M; Fattore L; Satta V; Businco F; Pigliacampo B; Goldberg SR; Dessi C; Fratta W; Fadda P
    Br J Pharmacol; 2013 Jun; 169(4):820-33. PubMed ID: 23072421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal from Extended, Intermittent Access to A Highly Palatable Diet Impairs Hippocampal Memory Function and Neurogenesis: Effects of Memantine.
    Ferragud A; Velázquez-Sánchez C; Abdullatif AA; Sabino V; Cottone P
    Nutrients; 2020 May; 12(5):. PubMed ID: 32456193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus.
    Rorato R; Miyahara C; Antunes-Rodrigues J; Elias LL
    Regul Pept; 2013 Mar; 182():12-8. PubMed ID: 23327999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
    Järbe TU; DiPatrizio NV
    Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
    Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F
    Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
    Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
    Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.